China Universal Asset Management »

Kura Oncology shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Kura Oncology (KURA) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Kura Oncology

Tip: Access up to 7 years of quarterly data

All positions including Kura Oncology held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kura Oncology by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $333k 16k 21.32
2023-12-31 $124k 8.6k 14.44
2023-09-30 $17k 1.9k 8.96
2023-06-30 $9.0k 897 10.03
2023-03-31 $11k 928 11.85
2022-12-31 $9.0k 693 12.99
2022-09-30 $9.0k 626 14.38

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Kura Oncology

BVF
EcoR1 Capital
Deerfield Management Company
Vanguard Group
venBio Select Advisor
Holocene Advisors
Dimensional Fund Advisors
Artal Group
Franklin Resources
Paradigm Biocapital Advisors
Commodore Capital
Assenagon Asset Management
Citadel Advisors
Bank of America Corporation
Sphera Funds Management

View all funds holding Kura Oncology